share_log

4: Statement of changes in beneficial ownership of securities-Officer Lenkowsky Adam

SEC ·  May 4 06:47
Summary by Futu AI
Adam Lenkowsky, EVP and Chief Commercial Officer of Bristol-Myers Squibb (BMY), reported a transaction on May 1, 2024, involving the company's common stock. Following the transaction, Lenkowsky holds a total of 6,650 shares directly and 9,651.639 shares indirectly. The indirect holdings include 4,364.699 shares through the BMS Savings and Investment Program and 5,286.94 shares held by his spouse. The common stock is listed with a par value of $0.10.
Adam Lenkowsky, EVP and Chief Commercial Officer of Bristol-Myers Squibb (BMY), reported a transaction on May 1, 2024, involving the company's common stock. Following the transaction, Lenkowsky holds a total of 6,650 shares directly and 9,651.639 shares indirectly. The indirect holdings include 4,364.699 shares through the BMS Savings and Investment Program and 5,286.94 shares held by his spouse. The common stock is listed with a par value of $0.10.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.